Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Sigrun Thorsteinsdottir, MD, Ingigerdur S Sverrisdottir, MD, Gauti Gislason, MSc, Ola Landgren, MD PhD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2018-99-115403

Published: 2018

Journal Articles

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Gudbjorg Jonsdottir, MD, Magnus Bjorkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Ola Landgren, MD PhD, Sigurdur Y. Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4396.

https://doi.org/10.1182/blood.V130.Suppl_1.4396.4396

Published: 2017

Journal Articles

Markers for Increased Thrombotic Risk within the Complete Blood Count

Sæmundur Rögnvaldsson, Sigrún H. Lund, PhD, Malin Hultcrantz, MD PhD, Signý Vala Sveinsdóttir, MD PhD, Guðný Eiríksdóttir, Tamara B Harris, MD, Vilmundur Guðnason, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 1429.

https://doi.org/10.1182/blood.V128.22.1429.1429

Published: 2016

Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3246.

https://doi.org/10.1182/blood.V128.22.3246.3246

Published: 2016

Journal Articles

Dietary Pattern and Risk of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study

Marianna Thordardottir, Ebba K Lindqvist, MD, Sigrun H Lund, PhD, Rene Costello, Johanna E Torfadottir, PhD, Bryndis E Birgisdottir, PhD, Debra Burton, Laufey Steingrimsdottir, PhD, Neha S Korde, MD, Sham Mailankody, MD, Gudny Eiriksdottir, Lenore J Launer, PhD, Tamara B Harris, MD, Ola Landgren, MDPhD, Vilmundur Gudnason, MDPhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3257.

https://doi.org/10.1182/blood.V128.22.3257.3257

Published: 2016

Journal Articles

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Ebba K Lindqvist, MD, Sigrun H Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MD, Magnus Björkholm, MD, PhD, Gudny Eiriksdottir, Leonore J Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Vilmundur Gudnason, MD PhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 5650.

https://doi.org/10.1182/blood.V128.22.5650.5650

Published: 2016

Journal Articles

Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013

Brendan M. Weiss, MD, Sigrun H Lund, PhD, Magnus Bjorkholm, Adam D. Cohen, MD, Laura Dember, MD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 4448.

https://doi.org/10.1182/blood.V128.22.4448.4448

Published: 2016

Journal Articles

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

Maria Creignou, MD, Hannah Bower, MSc, Therese M-L Andersson, MSc PhD, Anna Ravn Landtblom, MD, Paul W Dickman, MSc PhD, Magnus Björkholm, MD, PhD, Sigurdur Y Kristinsson, MD, PhD, Malin Hultcrantz, MDPhD

Blood (2016) 128 (22): 946.

https://doi.org/10.1182/blood.V128.22.946.946

Published: 2016

Journal Articles

No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study

Ebba K Lindqvist, MD, Sigrún H. Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MBBS, Vilmundur Gudnason, MD PhD, Gudny Eiriksdottir, Leonore Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD PhD, Magnus Bjorkholm, MD PhD

Blood (2015) 126 (23): 4252.

https://doi.org/10.1182/blood.V126.23.4252.4252

Published: 2015

Journal Articles

A Population-Based Study of Incidence of Myeloproliferative Neoplasms in Sweden Between 2000 and 2012

Malin Hultcrantz, MDPhD, Therese M-L Andersson, MSc PhD, Ola Landgren, MD PhD, Paul W Dickman, MSc PhD, Bjorn Andreasson, MDPhD, Magnus Bjorkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2015) 126 (23): 1605.

https://doi.org/10.1182/blood.V126.23.1605.1605

Published: 2015

Journal Articles

Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study

Sigrun Helga Lund, PhD, Malin Hultcrantz, MDPhD, Lynn Goldin, PhD, Ola Landgren, MD PhD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Sigurdur Y Kristinsson, MD, Ph., D

Blood (2014) 124 (21): 3350.

https://doi.org/10.1182/blood.V124.21.3350.3350

Published: 2014

Journal Articles

Obesity and Risk of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study

Marianna Thordardottir, PhDstudent, Sigrun Helga Lund, PhD, Ebba K Lindqvist, MD PhDStudent, Rene Costello, Debra Burton, Neha Korde, MD, Sham Mailankody, MD, Gudny Eiriksdottir, Lenore J Launer, PhD, Vilmundur Gudnason, MD PhD, Tamara B Harris, MD MS, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2014) 124 (21): 5706.

https://doi.org/10.1182/blood.V124.21.5706.5706

Published: 2014

Journal Articles

Risk of Arterial and Venous Thrombosis in 11,155 Patients with Myeloproliferative Neoplasms and 44,620 Matched Controls; A Population-Based Study

Malin Hultcrantz, MDPhD, Therese M-L Andersson, PhD, Ola Landgren, MD, PhD, Asa Rangert Derolf, MDPhD, Paul W Dickman, PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2014) 124 (21): 632.

https://doi.org/10.1182/blood.V124.21.632.632

Published: 2014

Journal Articles

Does Heparin Have An Anti-Myeloma Effect? An Analysis On Individual Data From Three Randomized Studies of GIMEMA, Nordic and Turkish Myeloma Study Groups,

Meral Beksac, MD, Anders Waage, MD, PhD, Sara Bringhen, MD, Sigurdur Y Kristinsson, MD PhD, Gulsan Sucak, MD, Peter Gimsing, MD, PhD, Lupparelli Giulia, PhD, Tulin Firatli Tuglular, MD, Gunnar Juliusson, MD PhD, Antonio Palumbo, MD

Blood (2011) 118 (21): 3970.

https://doi.org/10.1182/blood.V118.21.3970.3970

Published: 2011

Journal Articles

Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008

Malin Hultcrantz, Sigurdur Y. Kristinsson, MD, PhD, Therese M-L Andersson, Sandra Eloranta, Åsa Rangert Derolf, Ola Landgren, M.D., Ph.D., Paul W Dickman, Magnus Bjorkholm

Blood (2010) 116 (21): 3071.

https://doi.org/10.1182/blood.V116.21.3071.3071

Published: 2010

Journal Articles

The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973–2008

Magnus Bjorkholm, MD, PhD, Lotta Ohm, MD, Sandra Eloranta, Statistician, Åsa Rangert Derolf, MD, PhD, Malin Hultcrantz, MD, Jan Sjöberg, MD, PhD, Therese Andersson, Biostatistician, Martin Hoglund, MD, PhD, Johan Richter, MD, PhD, Ola Landgren, MD, Ph, D, Sigurdur Y. Kristinsson, MD, PhD, Paul W. Dickman, Biostatistician

Blood (2010) 116 (21): 205.

https://doi.org/10.1182/blood.V116.21.205.205

Published: 2010

Journal Articles

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Sigurdur Y. Kristinsson, MD, PhD, Tang Min, PhD, Ruth Pfeiffer, PhD, Magnus Björkholm, MD, PhD, Lynn Goldin, PhD, Cecilie Blimark, MD, Ulf-Henrik Mellqvist, MD, PhD, Anders Wahlin, MD, PhD, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD

Blood (2010) 116 (21): 4053.

https://doi.org/10.1182/blood.V116.21.4053.4053

Published: 2010

Journal Articles

African-American Multiple Myeloma Patients Have a Better Survival Than Caucasian Patients: a Population-Based Study Including 28,636 Patients.

Ola Landgren, MD, PhD, Susan Devesa, PhD, Pamela Mink, PhD, William F Anderson, MD, Brendan Weiss, MD, Sigurdur Y Kristinsson, MD, PhD, Katherine McGlynn, PhD

Blood (2009) 114 (22): 1832.

https://doi.org/10.1182/blood.V114.22.1832.1832

Published: 2009

Journal Articles

High Socioeconomic Status (SES) Is Associated with Superior Survival in Patients with Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM). A Population-Based Study.

Sigurdur Y. Kristinsson, MD, Asa R. Derolf, MD, Paul W. Dickman, PhD, Gustaf Edgren, Magnus Bjorkholm, PhD

Blood (2007) 110 (11): 1485.

https://doi.org/10.1182/blood.V110.11.1485.1485

Published: 2007

Journal Articles

Increased Risks of Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Myelofibrosis (MF) among 24577 First-Degree Relatives of 11039 Patients with Chronic Myeloproliferative Disorders (MPD) in Sweden.

Ola Landgren, MD, PhD, Lynn R. Goldin, PhD, Sigurdur Y. Kristinsson, MD, Jan Samuelsson, MD, PhD, Magnus Bjorkholm, Md PhD

Blood (2007) 110 (11): 680.

https://doi.org/10.1182/blood.V110.11.680.680

Published: 2007

NARROW

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Markers for Increased Thrombotic Risk within the Complete Blood Count

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Dietary Pattern and Risk of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Improved Survival in AL Amyloidosis: A Population-Based Study on 1,430 Patients Diagnosed in Sweden 1995-2013

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study

A Population-Based Study of Incidence of Myeloproliferative Neoplasms in Sweden Between 2000 and 2012

Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study

Obesity and Risk of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study

Risk of Arterial and Venous Thrombosis in 11,155 Patients with Myeloproliferative Neoplasms and 44,620 Matched Controls; A Population-Based Study

Does Heparin Have An Anti-Myeloma Effect? An Analysis On Individual Data From Three Randomized Studies of GIMEMA, Nordic and Turkish Myeloma Study Groups,

Patterns of Survival and Causes of Death In 9,384 Patients with Myeloproliferative Neoplasms Diagnosed In Sweden Between 1973 and 2008

The Success Story of Targeted Therapy In Chronic Myeloid Leukemia: A Population-Based Study of 3,173 Patients Diagnosed In Sweden 1973–2008

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

African-American Multiple Myeloma Patients Have a Better Survival Than Caucasian Patients: a Population-Based Study Including 28,636 Patients.

High Socioeconomic Status (SES) Is Associated with Superior Survival in Patients with Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM). A Population-Based Study.

Increased Risks of Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Myelofibrosis (MF) among 24577 First-Degree Relatives of 11039 Patients with Chronic Myeloproliferative Disorders (MPD) in Sweden.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only